MDCT.net - Scanning technology resources for healthcare professionals. A practical approach

THIS MONTH’S HIGHLIGHT

MDCT.net voices: CT technology as an accurate diagnostic tool for immune-related adverse events and for hepatocellular carcinoma

Dear readers,

The series of Professor Eisenblätter’s podcasts, dedicated to the fundamental role of CT imaging in the oncologic setting, progresses. Two new podcasts are now on air, related to the use of CT for identifying immune-related adverse events and for the proper staging of liver lesions, respectively.

Both topics are also described in the two selected papers, while the three cases from the MDCT.net archive linked below show the essential advantages of CT technology in the diagnosis of hepatocellular carcinoma.

As usual, suggestions for topics to be covered in future issues of this newsletter are welcome:
please send us your proposals at editorial@mdct.net.

From the MDCT.net team

---

MDCT.NET VOICES - A PODCAST SERIES

Oncologic CT imaging
M. Eisenblätter

Three sets of podcasts by Professor Michel Eisenblätter on the contribution of CT imaging in
cancer diagnosis and for supporting cancer treatment monitoring

Detection and differentiation of the adverse effects of novel cancer therapies (Oncologic CT imaging Series – Ep. 3)
A detailed description of the advantages of CT imaging in correctly identifying the most frequent and harmful adverse effects induced by immunotherapy Listen »

Staging of hepatocellular carcinoma and introduction to CT-based LI-RADS (Oncologic CT imaging Series – Ep. 4)
An introduction to the usefulness of CT imaging for the study of hepatocellular carcinoma and to the CT staging of liver lesions based on LI-RADS Listen »

---

SELECTED LITERATURE

Pourvaziri A, Parakh A, Biondetti P et al. Abdominal CT manifestations of adverse events to immunotherapy: a primer for radiologists. Abdom Radiol (NY). 2020 Sep;45(9):2624-2636.

Cho MJ, An C, Aljoqiman KS et al. Diagnostic performance of Liver Imaging Reporting and Data System in patients at risk of both hepatocellular carcinoma and metastasis. Abdom Radiol (NY). 2020 Nov;45(11):3789-3799.

---

CLINICAL CASE FROM THE MDCT.NET ARCHIVE

---
---